acinetobacter baumannii

Objective To understand clinical distribution and drug-resistance features of Acinetobacter baumannii.

If treatment was on the basis of drug sensitivity results, it was of significance to the clinical treatment of Acinetobacter baumannii.

Objective To analyze the plasmid and resistant spectra and the location of the resistance gene of Acinetobacter baumannii .

Objective To monitor the nosocomial infection of Acinetobacter baumannii by amplified polymorphic DNA(RAPD) assay.

Imipenem and polymyxin E are the most effective antibiotics for Acinetobacter baumannii.

And to further explore the Pan-thoracotomy resistant Acinetobacter baumannii severe pneumonia, treatment and prognosis.

The results are disturbing because Acinetobacter baumannii has the propensity to develop resistance to almost all available antibiotics.

Conclusion: Proportion of nosocomial infection caused by Acinetobacter baumannii significantly increased.

The main microbes of sputum culture were Candida albicans, Pseudomonas aeruginosa and Acinetobacter baumannii.

ConclusionThe incident of infection of Acinetobacter baumannii continuously increased in. . .

Recently the clinician were challenged for infections due to multidrug-resistance Acinetobacter baumannii, even pandrug resistance.

Conclusion Infections of Acinetobacter baumannii increase year by year among in patients.

Objective To observe the clinical characteristics of hospital acquired pneumonia caused by Acinetobacter baumannii.

Objective To analyze the trend of antibiotic resistance of Acinetobacter baumannii (Abi) in our hospital in resent three years.

Results Acinetobacter baumannii strains were mainly isolated from specimens of intensive care unit(33. 3%) and of respiratory tract(90. 0%).

METHODS Analyse antibiotic susceptibility of 122 strains Acinetobacter baumannii in 2001 year detected by Kirby Bauer test with statistics.

abstract: Objective To know the clinical distribution and antibiotics resistance of PDR-AB(Pan-drug resistant acinetobacter baumannii).

Results Pneumonia caused by Acinetobacter baumannii occurred in the older and weak patients.

Methods A retrospective analysis were performed, 708 acinetobacter baumannii strains which were isolated in our hospital from 2005 to 2009.

abstract: OBJECTIVE To study the prevention strategy of the intracranial infection caused by Acinetobacter baumannii.

Analysis of Antibiotic Resistant Patterns and Clinical Distribution of Acinetobacter Baumannii in Nosocomial Infections

Distribution and antimicrobial resistance of Acinetobacter baumannii infection

Distribution and Antimicrobial Resistance of Acinetobacter baumannii Infection in Elderly Patients

Distribution of Acinetobacter baumannii infection and drug susceptibility analysis

Prevalence of integrons and analysis of resistance genes in integrons among Acinetobacter baumannii isolates from Nanjing region

Resistance Phenotype and Efflux Protein Gene Expression: Study of 51 Strains of Acinetobacter Baumannii

Investigation for main types of aminoglycoside-modifying gene of Acinetobacter baumannii in Nanjing region

Antibiotic Resistance of Acinetobacter Baumannii Isolated from Clinical Patients

Infection and Antimicrobial Resistance of Acinetobacter baumannii

Invasion of an Acinetobacter baumannii Train Isolated from Mandarin Fish

Drug Resistance Analysis in Orthopedics Isolations of Acinetobacter Baumannii

Antibiotics Resistance and Genetic Homology of Acinetobacter baumannii

Study on drug resistance of Acinetobacter baumannii isolated from department of medicine, surgery and ICU in hospitals

The investigating analysis of Acinetobacter baumannii infection in burning wound area

Analysis of Resistance for Clinical Isolated Strains of Acinetobacter Baumannii

Typing of Acinetobacter baumannii with enterbacterial repetitive intergenic consensus PCR

Changing Trend of Resistance to Antimicrobial Agents of Acinetobacter Baumannii in Vitro

Survey analysis of infection and drug resistance of Acinetobacter baumannii during

Evaluating Risk Factors for ICU Patients with CR-Acinetobacter baumannii Positive

Acinetobacter baumannii Infection and Drug-resistance: A Trend Analysis of Three Years

Studies on the resistance and outer membrane proteins of Acinetobacter baumannii

Drug resistance status of acinetobacter baumannii in montane hospital

Survey on gene mutations of quinolone-resistant Acinetobacter baumannii in Nanjing region of China

Analysis of gene homology in Acinetobacter baumannii isolates

Study on the resistant genes in clinical isolates of Acinetobacter baumannii

Microbiology and clinical analysis of six cases of hospital-acquired pneumonia caused by Acinetobacter baumannii

Resistance, plasmid profiles and gene typing of ESBLs-producing Acinetobacter baumannii

Analysis of antibiotic resistant patterns of 163 acinetobacter baumannii isolates

Treatment experience in 18 cases of pediatric severe scald with Acinetobacter baumannii infection

Use of Repeated PCR Fingerprint Technique to Investigate an Outbreak of Acinetobacter Baumannii in Respiratory ICU

Preliminary analysis on the treatment of infection caused by pandrug-resistant Acinetobacter baumannii

Results in statistical 582 strains of acinetobacter baumannii, clinical specimens with respiratory tract of 85. 40% mainly sources;

Clinical analysis of 26 cases of pneumonia caused by acinetobacter Baumannii